Stem cell transplant offers hope for patients with multiple sclerosis

Stem cells harvested from a person’s own bone marrow or blood, can safely slow progression of the most common form of the autoimmune disease, multiple sclerosis, or MS as it’s usually known, finds research published online in the Journal of Neurology Neurosurgery & Psychiatry.

Umoja to dose first patient with in vivo CAR-T by end of this year

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

August 1, 2024

J&J, Protagonist reveal two Phase 3 wins for oral IL-23 drug that’s expected to be a blockbuster

Johnson & Johnson and Protagonist Therapeutics announced two Phase 3 successes for their oral IL-23 drug, showcasing the first results out of an expansive pivotal

November 20, 2024

COVID-19 found to increase heart attack and stroke risks

An analysis of data in the UK Biobank has found that COVID-19 infection may increase the risk of heart attack, stroke and death from any

October 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.